Trial Profile

A Multicenter, Open-label, Randomised, Comparative, Parallel-Arm, Phase II Study to Assess Efficacy and Safety of Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Feb 2025 Results evaluating 48 weeks of BLV monotherapy ,published in the Liver International
14 Nov 2023 Results of a pooled analysis assessing relationship between BR and VR criteria with BLV treatment from W48 BLV (2 and 10 mg) data from two Phase 2 and one Phase 3 trials presented at The Liver Meeting 2023: 74th Annual Meeting of the American Association for the Study of Liver Diseases
14 Nov 2023 Baseline demographics and clinical characteristics of patients from NCT03546621, NCT02888106, NCT03852433 and NCT03852719, presented at The Liver Meeting 2023: 74th Annual Meeting of the American Association for the Study of Liver Diseases

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com